Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8924161 System for use in the treatment of diabetes

Patent 8924161 was granted and assigned to Abbott on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Abbott

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89241610

Patent Inventor Names

Piet Moerman0

Date of Patent

December 30, 2014

Patent Application Number

128547060

Date Filed

August 11, 2010

Patent Citations Received

‌

US Patent 11918350 Systems, methods, and devices for rotating insulin administration sites

‌

US Patent 12020797 Insulin and pramlintide delivery systems, methods, and devices

‌

US Patent 11992343 Systems, devices, and methods for fluid monitoring

‌

US Patent 11951278 Insulin monitoring and delivery system and method for CGM based fault detection and mitigation via metabolic state tracking

‌

US Patent 11865241 Sensor monitoring system for in-dwelling catheter based treatments

‌

US Patent 11878145 Closed loop control of physiological glucose

Patent Primary Examiner

‌

Larry D Riggs, II

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8924161 System for use in the treatment of diabetes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API